IL6 and nasopharyngeal carcinoma: Zheng et al. [37] showed that IL-1–mediated IL6 expression was significantly repressed by miR-497 via the MAPK/ERK pathway, suggesting that miR-497 may play a suppressive role in inflammation-related cancers such as NPC [38].